Publicacións nas que colabora con Maria Victoria Milanes Maquilon (16)

2023

  1. Morphine-withdrawal aversive memories and their extinction modulate H4K5 acetylation and Brd4 activation in the rat hippocampus and basolateral amygdala

    Biomedicine and Pharmacotherapy, Vol. 165

2022

  1. Molecular Mechanisms Underlying the Retrieval and Extinction of Morphine Withdrawal-Associated Memories in the Basolateral Amygdala and Dentate Gyrus

    Biomedicines, Vol. 10, Núm. 3

2021

  1. Distinct regulation of dopamine d3 receptor in the basolateral amygdala and dentate gyrus during the reinstatement of cocaine cpp induced by drug priming and social stress

    International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-25

  2. Unraveling the molecular mechanisms involved in alcohol intake and withdrawal in adolescent mice exposed to alcohol during early life stages

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 104

2020

  1. Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1300-1315

2010

  1. Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 382, Núm. 5-6, pp. 525-534

  2. Increased spinal dynorphin levels and phospho-extracellular signal-regulated kinases 1 and 2 and c-Fos immunoreactivity after surgery under remifentanil anesthesia in mice

    Molecular Pharmacology, Vol. 77, Núm. 2, pp. 185-194

2009

  1. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus

    European Journal of Pharmacology, Vol. 620, Núm. 1-3, pp. 1-8

2007

  1. Differential involvement of 3′, 5′-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Núm. 4, pp. 293-303

  2. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart

    European Journal of Pharmacology, Vol. 570, Núm. 1-3, pp. 1-9

2004

  1. Changes in c-fos expression in the rat during morphine withdrawal. Involvement of α2-adrenoceptors

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Núm. 1, pp. 17-25

  2. Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart

    European Journal of Pharmacology, Vol. 506, Núm. 2, pp. 119-128

  3. Morphine withdrawal-induced c-fos expression in the heart: A peripheral mechanism

    European Journal of Pharmacology, Vol. 487, Núm. 1-3, pp. 117-124

2003

  1. Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal

    British Journal of Pharmacology, Vol. 138, Núm. 4, pp. 626-633

2001

  1. Evidence for a peripheral mechanism in cardiac opioid withdrawal

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 364, Núm. 3, pp. 193-198

2000

  1. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: Implication of α1- and α2-adrenoceptors

    Journal of Pharmacology and Experimental Therapeutics, Vol. 293, Núm. 2, pp. 578-584